These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25256233)

  • 1. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
    Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
    J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
    Kayashima Y; Makhanova N; Maeda N
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression.
    Subramanian M; Proto JD; Matsushima GK; Tabas I
    Sci Rep; 2016 Dec; 6():39111. PubMed ID: 27958361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.
    Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Lesèche G; Cohen PL; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1429-31. PubMed ID: 18467644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
    Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
    J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet.
    Kusters DH; Chatrou ML; Willems BA; De Saint-Hubert M; Bauwens M; van der Vorst E; Bena S; Biessen EA; Perretti M; Schurgers LJ; Reutelingsperger CP
    PLoS One; 2015; 10(6):e0130484. PubMed ID: 26090792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
    Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
    Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
    Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.
    Parma L; Peters HAB; Baganha F; Sluimer JC; de Vries MR; Quax PHA
    Cells; 2020 Feb; 9(2):. PubMed ID: 32024075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.
    Kiouptsi K; Pontarollo G; Todorov H; Braun J; Jäckel S; Koeck T; Bayer F; Karwot C; Karpi A; Gerber S; Jansen Y; Wild P; Ruf W; Daiber A; Van Der Vorst E; Weber C; Döring Y; Reinhardt C
    Gut Microbes; 2020 Nov; 11(6):1809-1823. PubMed ID: 32579470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.
    Medina I; Cougoule C; Drechsler M; Bermudez B; Koenen RR; Sluimer J; Wolfs I; Döring Y; Herias V; Gijbels M; Bot I; de Jager S; Weber C; Cleutjens J; van Berkel TJC; Sikkink KJ; Mócsai A; Maridonneau-Parini I; Soehnlein O; Biessen EAL
    Circulation; 2015 Aug; 132(6):490-501. PubMed ID: 26068045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
    Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S
    PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis.
    Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP
    Circ Res; 2009 Nov; 105(11):1141-8. PubMed ID: 19834008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.
    Yancey PG; Blakemore J; Ding L; Fan D; Overton CD; Zhang Y; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):787-95. PubMed ID: 20150557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
    Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
    Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.